Title
An explanatory factor analysis of a brief self-report scale to detect neurocognitive impairment among HIV-positive men who have sex with men and transgender women in Peru
Date Issued
03 October 2017
Access level
open access
Resource Type
Journal
Author(s)
Weikum D.
Shrestha R.
Ferro E.G.
Vagenas P.
Copenhaver M.
Spudich S.
Alpert M.D.
Cabello R.
Sanchez J.
Altice F.L.
Publisher(s)
Taylor & Francis
Abstract
Neurocognitive impairment (NCI) has been associated with poor clinical outcomes in various patient populations. This study used exploratory factor analysis (EFA) to examine the factor structure of the existing 95-item Neuropsychological Impairment Scale (NIS) to create a suitable NCI screening instrument for people living with HIV (PLH). In Lima, Peru, 313 HIV-positive men who have sex with men (MSM) and transgender women (TGW) prescribed antiretroviral therapy (ART) completed the NIS using computer-assisted self-interviews (CASI). The EFA used principal axis factoring and orthogonal varimax rotation, which resulted in 42 items with an 8-factor solution that explained 51.8% of the overall variance. The revised, 8-factor, Brief Inventory of Neurocognitive Impairment for Peru (BINI-P) showed a diverse set of factors with excellent to good reliability (i.e., F1 α = 0.92 to F8 α = 0.78). This EFA supports the use of the BINI-P to screen for NCI among Spanish-speaking, HIV-positive MSM and TGW. Future research should examine the effectiveness of the BINI-P in detecting NCI in clinical care settings and the impact of NCI on HIV health-related outcomes, including linkage and retention in care, ART adherence and HIV risk behaviors.
Start page
1297
End page
1301
Volume
29
Issue
10
Language
English
OCDE Knowledge area
Dermatología, Enfermedades venéreas
Neurología clínica
Subjects
Scopus EID
2-s2.0-85018165196
PubMed ID
Source
AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV
ISSN of the container
09540121
Source funding
Asociacion Civil Impacta Salud y Educacion
National Institute on Drug Abuse
Yale College
Sponsor(s)
This research was funded by Yale College through the Fellowship for Research in Health Studies, the Thomas C. Barry Travel Fellowship, the CIPE Spanish and Latin America Fellowship and the International Summer Award. Additional funding was provided by the National Institute on Drug Abuse [grant number K24 DA017072 to FLA], [grant number K02 DA033139 to MMC] and by core funds from Asociacion Civil Impacta Salud y Educacion. Funding sources played no role in study design, data collection, data analysis, data interpretation, writing of the manuscript or the decision to submit the paper for publication.
Sources of information:
Directorio de Producción Científica
Scopus